Hemant K. Parekh

Affiliations: 
Pathology Temple University, Philadelphia, PA, United States 
Area:
Molecular Biology
Google:
"Hemant Parekh"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chen J, Solomides C, Parekh H, et al. (2015) Cisplatin resistance in human cervical, ovarian and lung cancer cells. Cancer Chemotherapy and Pharmacology. 75: 1217-27
Lai PA, Parekh HK, Lin J, et al. (2014) P009 Human Immunology. 75: 55
Geier SS, Lai PA, Lin J, et al. (2014) P008 Human Immunology. 75: 54
Chen J, Emara N, Solomides C, et al. (2010) Resistance to platinum-based chemotherapy in lung cancer cell lines Cancer Chemotherapy and Pharmacology. 66: 1103-1111
Pallai R, Simpkins H, Chen J, et al. (2010) The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene. Gene. 459: 11-23
Rajash P, Simpkins H, Chen J, et al. (2010) Abstract 4990: Nuclear Factor-Y (NF-Y) regulates the transcription of the human aldo-keto reductase 1C1 (AKR1C1) gene* Cancer Research. 70: 4990-4990
Chen J, Adikari M, Pallai R, et al. (2008) Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 61: 979-87
Parekh HK, Adikari M, Vennapusa B. (2006) Differential partitioning of Galphai1 with the cellular microtubules: a possible mechanism of development of Taxol resistance in human ovarian carcinoma cells. Journal of Molecular Signaling. 1: 3
Isordia-Salas I, Manns JM, Sainz I, et al. (2005) Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line. Thrombosis Research. 116: 533-43
Deng HB, Adikari M, Parekh HK, et al. (2004) Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase. Cancer Chemotherapy and Pharmacology. 54: 301-7
See more...